Abstract: The present disclosure relates to customized therapy for disease. The present disclosure also relates to aptamer-based compositions and methods for identifying, modulating and monitoring drug targets in muscular disease (e.g., Duchenne muscular dystrophy).

Abstract: The present disclosure relates to customized therapy for disease. The present disclosure also relates to aptamer-based compositions and methods for identifying, modulating and monitoring drug targets in muscular disease (e.g., Duchenne muscular dystrophy).

Abstract: A device, for use by a transcriptionist in a transcription editing system for editing transcriptions dictated by speakers, includes, in combination, a monitor configured to display visual text of transcribed dictations, an audio mechanism configured to cause playback of portions of an audio file associated with a dictation, and a cursor-control module coupled to the audio mechanism and to the monitor and configured to cause the monitor to display multiple cursors in the text.

Abstract: A device, for use by a transcriptionist in a transcription editing system for editing transcriptions dictated by speakers, includes, in combination, a monitor configured to display visual text of transcribed dictations, an audio mechanism configured to cause playback of portions of an audio file associated with a dictation, and a cursor-control module coupled to the audio mechanism and to the monitor and configured to cause the monitor to display multiple cursors in the text.

Abstract: The present application includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of ovarian cancer. In one aspect, the application provides biomarkers that can be used alone or in various combinations to diagnose ovarian cancer or permit the differential diagnosis of a pelvic mass as benign or malignant. In another aspect, methods are provided for diagnosing ovarian cancer in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 1, wherein the individual is classified as having ovarian cancer, or the likelihood of the individual having ovarian cancer is determined, based on the at least one biomarker value.

Abstract: A method and system are disclosed for conducting electronic commerce over a computer network. A first processor can be configured to receive first data including information of a buyer, and generate second data based on the first data. The first processor sends the second data to the second processor and the second processor processes the second data which causes a product and/or service to be provided to the buyer. The second processor does not receive first data.

Abstract: A method of, and system for, facilitating electronic commerce transaction comprises: steps for, or server component, receiving an indication of purchase of a first product from a first seller, sending an offer for a second product of a second seller to the first seller, allowing the first seller to accept and complete purchase of the second product without providing billing information of the customer to the second seller. The method and system may further provide a subscription management of multiple subscriptions from different subscription sellers.